Product Portfolio
Marketed Therapies
Below is a list of our company's marketed products. This information is intended only for residents of New Zealand.
AVONEX (INTERFERON BETA-1A)
Registered in New Zealand January 2002
TECFIDERA (DIMETHYL FUMARATE)
Registered in New Zealand July 2014
TYSABRI (NATALIZUMAB)
Registered in New Zealand September 2007